Kimberly Gentile

Overview

Kimberly Gentile received an average of $3M in total compensation, including $350K in salary, at Biohaven Pharmaceutical Holding Co Ltd. between 2018 and 2019.

Source: SEC filings on March 20, 2020 and April 11, 2019.

Related executives

We found six more executives who work or worked at Biohaven Pharmaceutical Holding Co Ltd..

Vlad Coric

Biohaven Pharmaceutical Holding Co Ltd.

Chief Executive Officer

William Jones

Biohaven Pharmaceutical Holding Co Ltd.

Chief Commercial Officer of Migraine & Common Diseases

James Engelhart

Biohaven Pharmaceutical Holding Co Ltd.

Chief Financial Officer

Elyse Stock

Biohaven Pharmaceutical Holding Co Ltd.

Chief Medical Officer

Charles Conway

Biohaven Pharmaceutical Holding Co Ltd.

Chief Scientific Officer

John Tilton

Biohaven Pharmaceutical Holding Co Ltd.

Chief Commercial Officer

News

You may also like